Spodoptera frugiperda Sf9 cells (ATCC, CRL-1711) were cultured in
Grace’s insect medium (Gibco) supplemented with 10% FBS, 1% penicillin-streptomycin, and 0.1%
Pluronic F68 solution (Gibco) at 28 °C without CO
2. High Five Cells (BTI-TN-5B1-4, Invitrogen) were maintained in
Express Five SFM medium (Gibco) supplemented with
l-Glutamine and 1% penicillin-streptomycin. We used
Grace’s insect medium (Gibco) supplemented with 3% FBS, 1% penicillin-streptomycin, and 0.1%
Pluronic F68 solution to amplify the recombinant baculoviruses.
Rabbit antisera against GP (C2023) and VP40, which have been described previously [32 (
link),33 (
link)], and mouse monoclonal antibodies against Ebola GP protein (mAb 42/3.71 or mAb 12/1.1; kindly provided by Dr. Ayato Takada, Hokkaido University, Hokkaido, Japan) were used for Western blot analysis. A monoclonal antibody against Ebola GP protein (mAb 42/3.71) was also used as an ELISA positive control.
The GP and VP40 cDNAs sequences were consistent with those of Zaire ebolavirus Ebola virus/H.sapiens-wt/SLE/2014/Makona-G3750.2, which was isolated from a patient during the 2014–2016 Ebola outbreak in West Africa (GenBank accession No. KM233059).
Feng H., Nakatsu S., Lopes T.J., Imai M., Yamayoshi S., Yamashita M., Watanabe T, & Kawaoka Y. (2020). Identification of Novel Adjuvants for Ebola Virus-Like Particle Vaccine. Vaccines, 8(2), 215.